The FDA has issued a warning about bottles supposedly containing montelukast sodium pills, which the manufacturer voluntarily recalled after finding they actually contained losartan.
A recent analysis found that methadone or buprenorphine is an underused treatment for opioid use disorder following an overdose.
The FDA recently approved a prophylactic treatment for hemophilia A, called Jivi, which showed bleed protection in a clinical trial.
Experts discuss how to enhance prescription drug monitoring programs for opioids, spot at-risk patients, and improve treatment for patients who misuse the drugs.
A test used to inform treatment of major depressive disorder led to improved quality of life and reduced medical costs, according to a new study.
Pharmacy Practice Report is brought to MedPage Today readers by our friends at Pharmacy Practice News, a McMahon Group title. Registration (free) may be required for some content.
Article by:
